Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TEN
2776
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $1.07M | ﹤0.01% |
94,564
+59,558
| +170% | +$744K |
|
2777
Bionano Genomics
BNGO
$12.3M
| $1.06M | ﹤0.01% |
594
+398
| +203% | +$1.06M |
|
2778
PUT
ProShares UltraPro QQQ
TQQQ
$32.1B
| $1.06M | ﹤0.01% |
25,600
| – | – |
|
2779
Citi Trends
CTRN
$555M
| $1.06M | ﹤0.01% |
11,207
+3,914
| +54% | +$312K |
|
2780
Silicon Motion
SIMO
$8.6B
| $1.06M | ﹤0.01% |
11,157
-22,150
| -67% | -$1.67M |
|
2781
WisdomTree
WT
$2.96B
| $1.06M | ﹤0.01% |
173,566
+76,000
| +78% | +$471K |
|
|
SJR
2782
DELISTED
Shaw Communications Inc.
SJR
| $1.06M | ﹤0.01% |
34,974
-81,381
| -70% | -$2.38M |
|
2783
Nektar Therapeutics
NKTR
$2.39B
| $1.06M | ﹤0.01% |
5,224
-4,097
| -44% | -$889K |
|
|
CVGW
2784
DELISTED
Calavo Growers
CVGW
| $1.06M | ﹤0.01% |
24,931
+2,146
| +9% | +$87.9K |
|
|
HNGR
2785
DELISTED
Hanger Inc.
HNGR
| $1.06M | ﹤0.01% |
58,343
+15,691
| +37% | +$292K |
|
2786
Arbutus Biopharma
ABUS
$857M
| $1.05M | ﹤0.01% |
271,454
-364,002
| -57% | -$1.41M |
|
|
GDEN
2787
DELISTED
Golden Entertainment
GDEN
| $1.05M | ﹤0.01% |
20,837
-1,664
| -7% | -$82.4K |
|
2788
Peapack-Gladstone Financial
PGC
$815M
| $1.05M | ﹤0.01% |
29,662
+22,012
| +288% | +$755K |
|
2789
Mine Safety
MSA
$7.35B
| $1.05M | ﹤0.01% |
6,947
-28,888
| -81% | -$4.33M |
|
|
PETQ
2790
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.05M | ﹤0.01% |
46,122
+21,432
| +87% | +$501K |
|
|
NTUS
2791
DELISTED
Natus Medical Inc
NTUS
| $1.05M | ﹤0.01% |
44,086
+13,801
| +46% | +$341K |
|
2792
Comstock Resources
CRK
$3.89B
| $1.04M | ﹤0.01% |
129,183
+71,500
| +124% | +$653K |
|
2793
Uranium Energy
UEC
$4.75B
| $1.04M | ﹤0.01% |
312,125
+217,127
| +229% | +$836K |
|
2794
Theravance Biopharma
TBPH
$874M
| $1.04M | ﹤0.01% |
94,409
+35,619
| +61% | +$310K |
|
2795
America Movil
AMX
$76.1B
| $1.04M | ﹤0.01% |
49,373
-201,487
| -80% | -$3.71M |
|
2796
Winmark
WINA
$1.2B
| $1.04M | ﹤0.01% |
4,202
+2,786
| +197% | +$674K |
|
2797
Construction Partners
ROAD
$5.84B
| $1.04M | ﹤0.01% |
35,336
+23,438
| +197% | +$818K |
|
2798
Ezcorp Inc
EZPW
$1.83B
| $1.04M | ﹤0.01% |
140,878
+23,866
| +20% | +$181K |
|
|
UHT
2799
Universal Health Realty Income Trust
UHT
$603M
| $1.04M | ﹤0.01% |
17,459
+3,082
| +21% | +$179K |
|
2800
National Healthcare
NHC
$3.53B
| $1.04M | ﹤0.01% |
15,245
+4,678
| +44% | +$324K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.